Genital warts/condyloma acuminata is the most common mucosal human papillomavirus (HPV)
infection encountered by the dermatologists. They can be asymptomatic or symptomatic. They can present as discrete lesions or confluent masses. Depending on the HPV strains, lesions can either be benign or may turn malignant. The treatment modalities for
genital warts range from topical, systemic, intralesional
immunotherapy, and surgical interventions (intralesional
immunotherapy has shown promising results in the treatment of viral and
genital warts). However, there are very few reports that have used Bacillus Calmette-Guérin (BCG) as
immunotherapy in
genital warts. Here, we report, in author's opinion, the first case of female vulvovaginal
warts successfully treated with intralesional BCG
immunotherapy, leading to complete resolution of injected
warts as well as near-distant
warts.